Aethlon Medical Statistics Share Statistics Aethlon Medical has 2.6M
shares outstanding. The number of shares has increased by 3.7%
in one year.
Shares Outstanding 2.6M Shares Change (YoY) 3.7% Shares Change (QoQ) -0.04% Owned by Institutions (%) 24.23% Shares Floating 2.49M Failed to Deliver (FTD) Shares 65 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 121.12K, so 4.66% of the outstanding
shares have been sold short.
Short Interest 121.12K Short % of Shares Out 4.66% Short % of Float 4.7% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.33 and the forward
PE ratio is -0.66.
Aethlon Medical's PEG ratio is
0.
PE Ratio -0.33 Forward PE -0.66 PS Ratio 0 Forward PS 0 PB Ratio 0.87 P/FCF Ratio -0.58 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aethlon Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.13,
with a Debt / Equity ratio of 0.13.
Current Ratio 3.13 Quick Ratio 3.13 Debt / Equity 0.13 Debt / EBITDA -0.05 Debt / FCF -0.08 Interest Coverage -924.06
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-956.29K Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -75.99% in the
last 52 weeks. The beta is 1.72, so Aethlon Medical's
price volatility has been higher than the market average.
Beta 1.72 52-Week Price Change -75.99% 50-Day Moving Average 1.33 200-Day Moving Average 3.11 Relative Strength Index (RSI) 37.84 Average Volume (20 Days) 2,911,741
Income Statement
Revenue n/a Gross Profit -339.56K Operating Income -9.34M Net Income -13.39M EBITDA -13.04M EBIT -13.38M Earnings Per Share (EPS) -8.58
Full Income Statement Balance Sheet The company has 5.5M in cash and 649.75K in
debt, giving a net cash position of 4.85M.
Cash & Cash Equivalents 5.5M Total Debt 649.75K Net Cash 4.85M Retained Earnings -167.95M Total Assets 5.31B Working Capital 2.42B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.65M
and capital expenditures 0, giving a free cash flow of -7.65M.
Operating Cash Flow -7.65M Capital Expenditures n/a Free Cash Flow -7.65M FCF Per Share -4.9
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields AEMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for AEMD is $1.5,
which is 105.5% higher than the current price. The consensus rating is "Hold".
Price Target $1.5 Price Target Difference 105.5% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 9, 2025. It was a
backward
split with a ratio of 1:8.
Last Split Date Jun 9, 2025 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -44.23 Piotroski F-Score 1
